Retrospective chart review study of use of cannabidiol (CBD) independent of concomitant clobazam use in patients with Lennox-Gastaut syndrome or Dravet syndrome
- DOI
- 10.1016/j.seizure.2023.05.003
- Published
- 2023-08
- Container
- Seizure: European Journal of Epilepsy
- Publisher
- Elsevier BV
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1016/j.seizure.2023.05.003,
title = {Retrospective chart review study of use of cannabidiol (CBD) independent of concomitant clobazam use in patients with Lennox-Gastaut syndrome or Dravet syndrome},
author = {Rima Nabbout and Alexis Arzimanoglou and Stéphane Auvin and Patrick Berquin and Archana Desurkar and Douglas Fuller and Charlotte Nortvedt and Patrizia Pulitano and Anna Rosati and Victor Soto and Vicente Villanueva and J. Helen Cross},
year = {2023},
journal = {Seizure: European Journal of Epilepsy},
doi = {10.1016/j.seizure.2023.05.003},
url = {https://doi.org/10.1016/j.seizure.2023.05.003}
}RIS
TY - JOUR TI - Retrospective chart review study of use of cannabidiol (CBD) independent of concomitant clobazam use in patients with Lennox-Gastaut syndrome or Dravet syndrome AU - Rima Nabbout AU - Alexis Arzimanoglou AU - Stéphane Auvin AU - Patrick Berquin AU - Archana Desurkar AU - Douglas Fuller AU - Charlotte Nortvedt AU - Patrizia Pulitano AU - Anna Rosati AU - Victor Soto AU - Vicente Villanueva AU - J. Helen Cross PY - 2023 JO - Seizure: European Journal of Epilepsy DO - 10.1016/j.seizure.2023.05.003 UR - https://doi.org/10.1016/j.seizure.2023.05.003 ER -
APA
Nabbout, R., Arzimanoglou, A., Auvin, S., Berquin, P., Desurkar, A., Fuller, D., Nortvedt, C., Pulitano, P., Rosati, A., Soto, V., Villanueva, V., & Cross, J. H. (2023). Retrospective chart review study of use of cannabidiol (CBD) independent of concomitant clobazam use in patients with Lennox-Gastaut syndrome or Dravet syndrome. Seizure: European Journal of Epilepsy. https://doi.org/10.1016/j.seizure.2023.05.003
Source records
- crossref · retrieved 2026-09-26T13:54:04.374Z